J-Curve Effect

J-Curve Effect describes a relationship where both very low and very high levels of a variable are associated with increased risk, producing a J-shaped curve when plotted. In biomedical contexts, this may apply to biomarkers, immune activity, or physiological parameters where extremes are harmful and optimal outcomes occur within a defined range rather than at minimum or maximum values.

The pharmaceutical industry considers J-curve effects when evaluating dose-response relationships, biomarker thresholds, and safety margins. Excessive suppression of immune pathways may increase infection risk, while insufficient suppression fails to control disease. Clinical development aims to identify therapeutic windows balancing benefit and risk within the safe and efficacious range. Statistical modelling and subgroup analyses explore potential J-curve relationships influencing labelling and dosing guidance. As precision dosing advances through pharmacokinetic modelling, biomarker-guided dosing, and therapeutic drug monitoring, J-curve considerations support development of safer, more effective treatment optimisation strategies across patient populations.